Antimicrobial nonwoven polyamides with zinc content
AssigneeAscend Performance Materials Operations LLC
InventorsScott E. Osborn, Wai-shing Yung, Albert Ortega
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a nonwoven polyamide structure having antimicrobial properties comprising: nonwoven polyamide fibers comprising less than 4000 ppm zinc dispersed within the nonwoven polyamide fibers; and less than 2000 ppm phosphorus. The fibers have an average fiber diameter of less than 25 microns; and the polyamide structure demonstrates a Staphylococcus aureus reduction of at least 90%, as measured by ISO 20743-13.
Claims18
A nonwoven polyamide structure having antimicrobial properties comprising:
- nonwoven polyamide fibers comprising a polyamide composition comprising:
- less than 4000 ppm zinc dispersed within the nonwoven polyamide fibers;
- and
- less than 2000 ppm phosphorus, wherein the fibers have an average fiber diameter of less than 15 microns;
- wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound;
- and
- wherein the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.
Antimicrobial fibers having antimicrobial properties comprising:
- a polymer;
- less than 4000 ppm zinc dispersed within the polymer;
- and
- less than 2000 ppm phosphorus,
- wherein the fibers have an average fiber diameter of less than 15 microns;
- wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound;
- and
- wherein the antimicrobial fibers demonstrate a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.
A medical device comprising nonwoven polyamide fibers having a polyamide composition comprising:
- less than 4000 ppm zinc dispersed within the nonwoven polyamide fibers;
- and
- less than 2000 ppm phosphorus,
- wherein the fibers have an average fiber diameter of less than 15 microns;
- wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound;
- and
- wherein the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.
Dependencies are inferred from the claim text.